STI
39
4
ADP
72
2
CSCO
56
2
BEN
30
-2
TSN
52
4
JNJ
62
2
WU
22
-4
NAVI
33
-3
CRM
49
2
SBUX
33
-6
THC
73
2
QRVO
53
12
KHC
45
3
CB
54
3
PEP
29
2
LMT
59
4
EA
47
-3
AZO
65
2
IP
45
-6
VIX
57
3
STI
39
4
ADP
72
2
CSCO
56
2
BEN
30
-2
TSN
52
4
JNJ
62
2
WU
22
-4
NAVI
33
-3
CRM
49
2
SBUX
33
-6
THC
73
2
QRVO
53
12
KHC
45
3
CB
54
3
PEP
29
2
LMT
59
4
EA
47
-3
AZO
65
2
IP
45
-6
VIX
57
3
Financhill
Back

Pliant Therapeutics 10K Form

Sell
30

PLRX
Pliant Therapeutics

Last Price:
$1.59
Seasonality Move:
24.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PLRX News And Ratings

See the #1 stock for the next 7 days that we like better than PLRX

PLRX Financial Statistics

Sales & Book Value

Annual Sales: $1.6M
Cash Flow: $-47.9M
Price / Cash Flow: 0
Annual Sales: $5.00
Price / Book: 0.32

Profitability

EPS (TTM): -3.47000
Net Income (TTM): $-210.3M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Pliant Therapeutics Earnings Forecast

Key Pliant Therapeutics Financial Ratios

  • Per Share Earnings over the last 7 years have been positive in 2 years.

Pliant Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: PLRX
CUSIP: 729139
Website: pliantrx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PLRX Technical Analysis vs Fundamental Analysis

Sell
30
Pliant Therapeutics (PLRX) is a Sell

Is Pliant Therapeutics a Buy or a Sell?